Literature DB >> 22647698

A specific domain of the Chikungunya virus E2 protein regulates particle formation in human cells: implications for alphavirus vaccine design.

Wataru Akahata1, Gary J Nabel.   

Abstract

Virus-like particles (VLPs) can be generated from Chikungunya virus (CHIKV), but different strains yield variable quantities of particles. Here, we define the genetic basis for these differences and show that amino acid 234 in E2 substantially affects VLP production. This site is located within the acid-sensitive region (ASR) known to initiate a major conformational change in E1/E2. Selected other mutations in the ASR, or changes in pH, also increased VLP yield. These results demonstrate that the ASR of E2 plays an important role in regulating particle generation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22647698      PMCID: PMC3421714          DOI: 10.1128/JVI.00370-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Molecular genetic study of the interaction of Sindbis virus E2 with Ross River virus E1 for virus budding.

Authors:  J Yao; E G Strauss; J H Strauss
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

2.  The heterodimeric association between the membrane proteins of Semliki Forest virus changes its sensitivity to low pH during virus maturation.

Authors:  J M Wahlberg; W A Boere; H Garoff
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

3.  Interactions between PE2, E1, and 6K required for assembly of alphaviruses studied with chimeric viruses.

Authors:  J S Yao; E G Strauss; J H Strauss
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

4.  The influence of antigen organization on B cell responsiveness.

Authors:  M F Bachmann; U H Rohrer; T M Kündig; K Bürki; H Hengartner; R M Zinkernagel
Journal:  Science       Date:  1993-11-26       Impact factor: 47.728

5.  Effects of site-directed mutations of transmembrane cysteines in sindbis virus E1 and E2 glycoproteins on palmitylation and virus replication.

Authors:  C Ryan; L Ivanova; M J Schlesinger
Journal:  Virology       Date:  1998-09-15       Impact factor: 3.616

6.  Immunogenicity of multiple gene and clade human immunodeficiency virus type 1 DNA vaccines.

Authors:  Wing-Pui Kong; Yue Huang; Zhi-Yong Yang; Bimal K Chakrabarti; Zoe Moodie; Gary J Nabel
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

7.  Identification of a protein binding site on the surface of the alphavirus nucleocapsid and its implication in virus assembly.

Authors:  S Lee; K E Owen; H K Choi; H Lee; G Lu; G Wengler; D T Brown; M G Rossmann; R J Kuhn
Journal:  Structure       Date:  1996-05-15       Impact factor: 5.006

8.  A tyrosine-based motif in the cytoplasmic domain of the alphavirus envelope protein is essential for budding.

Authors:  H Zhao; B Lindqvist; H Garoff; C H von Bonsdorff; P Liljeström
Journal:  EMBO J       Date:  1994-09-15       Impact factor: 11.598

9.  A single point mutation controls the cholesterol dependence of Semliki Forest virus entry and exit.

Authors:  M Vashishtha; T Phalen; M T Marquardt; J S Ryu; A C Ng; M Kielian
Journal:  J Cell Biol       Date:  1998-01-12       Impact factor: 10.539

10.  Cholesterol is required in the exit pathway of Semliki Forest virus.

Authors:  M T Marquardt; T Phalen; M Kielian
Journal:  J Cell Biol       Date:  1993-10       Impact factor: 10.539

View more
  21 in total

1.  An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.

Authors:  Akane Urakami; Mya Myat Ngwe Tun; Meng Ling Moi; Atsuko Sakurai; Momoko Ishikawa; Sachiko Kuno; Ryuji Ueno; Kouichi Morita; Wataru Akahata
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

2.  The alphavirus E3 glycoprotein functions in a clade-specific manner.

Authors:  Anthony J Snyder; Suchetana Mukhopadhyay
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

Review 3.  Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies.

Authors:  Laurie A Silva; Terence S Dermody
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

4.  Longitudinal analysis of the human antibody response to Chikungunya virus infection: implications for serodiagnosis and vaccine development.

Authors:  Yiu-Wing Kam; Wendy W L Lee; Diane Simarmata; Sumitro Harjanto; Terk-Shin Teng; Hugues Tolou; Angela Chow; Raymond T P Lin; Yee-Sin Leo; Laurent Rénia; Lisa F P Ng
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

5.  A key interaction between the alphavirus envelope proteins responsible for initial dimer dissociation during fusion.

Authors:  Whitney Fields; Margaret Kielian
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

6.  Prime-boost immunization strategies against Chikungunya virus.

Authors:  David Hallengärd; Fok-Moon Lum; Beate M Kümmerer; Aleksei Lulla; Valeria Lulla; Juan García-Arriaza; John K Fazakerley; Pierre Roques; Roger Le Grand; Andres Merits; Lisa F P Ng; Mariano Esteban; Peter Liljeström
Journal:  J Virol       Date:  2014-09-10       Impact factor: 5.103

Review 7.  Insights into Antibody-Mediated Alphavirus Immunity and Vaccine Development Landscape.

Authors:  Anthony Torres-Ruesta; Rhonda Sin-Ling Chee; Lisa F P Ng
Journal:  Microorganisms       Date:  2021-04-22

8.  Enhanced production of Chikungunya virus-like particles using a high-pH adapted spodoptera frugiperda insect cell line.

Authors:  James M Wagner; J David Pajerowski; Christopher L Daniels; Patrick M McHugh; Jessica A Flynn; John W Balliet; Danilo R Casimiro; Shyamsundar Subramanian
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

9.  Unique epitopes recognized by antibodies induced in Chikungunya virus-infected non-human primates: implications for the study of immunopathology and vaccine development.

Authors:  Yiu-Wing Kam; Wendy W L Lee; Diane Simarmata; Roger Le Grand; Hugues Tolou; Andres Merits; Pierre Roques; Lisa F P Ng
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

10.  A neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from disease.

Authors:  Suganya Selvarajah; Nicole R Sexton; Kristen M Kahle; Rachel H Fong; Kimberly-Anne Mattia; Joy Gardner; Kai Lu; Nathan M Liss; Beatriz Salvador; David F Tucker; Trevor Barnes; Manu Mabila; Xiangdong Zhou; Giada Rossini; Joseph B Rucker; David Avram Sanders; Andreas Suhrbier; Vittorio Sambri; Alain Michault; Marcus O Muench; Benjamin J Doranz; Graham Simmons
Journal:  PLoS Negl Trop Dis       Date:  2013-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.